Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Odiparcil

EU orphan designation number: EU/3/17/1903   
Active ingredient: Odiparcil
Indication: Treatment of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)
Sponsor: Inventiva
50 rue de Dijon, 21121 Daix, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/08/2017 Orphan designation EMA/OD/043/17 (2017)5912 of 23/08/2017
15/03/2018 Corrigendum (2018)1646 of 13/03/2018